HEALTHYWAY INC (02587) announced its intention to exercise the buyback authorization in the next five months, repurchasing its issued shares on the open market for a total consideration not exceeding HKD 100 million (the Proposed Buyback). The Proposed Buyback will be conducted in accordance with the company's articles of association, the Hong Kong Stock Exchange Listing Rules, the Codes on Takeovers and Mergers and Share Repurchases, the Cayman Islands Companies Law, and all other applicable laws and regulations. Any repurchased shares will be held as treasury shares, and the company may, at its discretion, cancel, dispose of, or use them for share incentives or other permitted purposes, depending on market conditions and the group's capital needs.

The board believes the Proposed Buyback reflects the company's confidence in its business prospects and will enhance shareholder value. The buyback will only proceed when the board deems it appropriate and in the best interests of the company and its shareholders. Additionally, the board confirms that the company has sufficient financial resources to execute the Proposed Buyback without compromising its financial position.

Furthermore, the Proposed Buyback will not reduce the public float below the minimum percentage required by the Listing Rules, nor will it trigger any mandatory general offer obligations under the Takeovers Code.